Novartis AG Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (50)

Latest Posts

About This Stock More About This Stock
Conatus Pharmaceuticals Launches Small Offering For Pipeline Expansion
Article By: Terry Chrisomalis
Friday, May 12, 2017 7:05 PM EDT
The offering doesn’t seem to make sense after the Novartis (NVS) licensing deal being signed.
In this article: CNAT, NVS, RHHBY
E Conatus Pharmaceuticals Announces Novartis Takes Option To License Emricasan
Article By: Terry Chrisomalis
Saturday, May 6, 2017 11:36 AM EDT
With the option being exercised by Novartis this now opens Conatus to many good perks.
In this article: CNAT, NVS
E Novartis Receives FDA Approval For An Acute Myeloid Leukemia Drug
Article By: Terry Chrisomalis
Sunday, April 30, 2017 11:36 AM EDT
On Friday, Novartis stated that it had won FDA approval for Rydapt, which is a drug developed to treat patients with Acute Myeloid Leukemia -- AML.
In this article: NVS
Biotech Digest – JAZZ Reports Positive Results, CTSO Inks New Contract, AMGN Forges Collaboration
Article By: KKD Healthcare Analytics
Tuesday, April 25, 2017 10:15 AM EDT
Capricor Therapeutics announced encouraging six-month results in a Phase 1/2 clinical trial. Jazz Pharmaceuticals reported results from its Phase 2/3 clinical trial. Amgen announced its new collaboration with Novartis.
Samsung Bioepis' Knockoff Latest Competition For Johnson & Johnson's Blockbuster, Remicade
Article By: Lorimer Wilson
Friday, April 21, 2017 8:34 PM EDT
JNJ’s Remicade earned close to $7 billion last year, making it by far the biggest drug in their portfolio but the FDA has approved a new knockoff which may finally start to shift the market dynamics toward greater competition with lower prices.
In this article: JNJ, MRK, NVS, PFE, BIIB


Latest Tweets for $NVS

No tweets yet!


Novartis Receives FDA Approval For An Acute Myeloid Leukemia Drug
Terry Chrisomalis 5/1/2017 12:22:24 AM

Yes it does indeed. #Novartis has been doing very well lately. $NVS

Novartis Receives FDA Approval For An Acute Myeloid Leukemia Drug
Danielle Rogers 4/30/2017 5:29:49 PM

Triple the effectiveness over a placebo looks very promising! $NVS

1 to 3 of 3 comments